1. Home /
  2. Fundamental Analysis

Fundamental Analysis

Economist Perspective: Why 2019 Will Be Different?

Economist Perspective: Why 2019 Will Be Different?

Will lag effects of interest rate hikes and the trade war with China show up in 2019?

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

With Tilray set to report earnings after today's closing bell, we're rewinding to our sit-down with CEO Brendan Kennedy.

Trader's Edge: WTI/Brent Spread

Trader's Edge: WTI/Brent Spread

Key advantages of using options when trading a WTI/Brent spread

Economist Perspective: Trade War

Economist Perspective: Trade War

Will the unintended effects of the trade war show up in 2019?

Striking Options: Elections, Equities, & Nasdaq

Striking Options: Elections, Equities, & Nasdaq

U.S. stocks rise as investors eagerly await U.S. midterm results

Market Movers: Trading Around Midterm Elections

Market Movers: Trading Around Midterm Elections

Power Balance: Will a shift in politics change investors risk appetite in the U.S. dollar and gold?

Jim Cramer: No One Took Price This Quarter Better Than Apple

Jim Cramer: No One Took Price This Quarter Better Than Apple

They are coining money selling phones and making even more - in terms of gross profit on the services stream.

Get Bearish on Shake Shack With This Options Play

Get Bearish on Shake Shack With This Options Play

SHAK beat expectations for both EPS and revenue, but same-store sales decreased. Here is how to play it.

These Are the U.S. Regions Most Affected by Retaliatory Tariffs

These Are the U.S. Regions Most Affected by Retaliatory Tariffs

Many local economies in the U.S. — cities, towns, and rural areas — depend on exports for economic growth and jobs.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.